Product Description
Mechanisms of Action: TRPV1 Modulator
Novel Mechanism: Yes
Modality: Unknown
Route of Administration: N/A
FDA Designation: *
Approval Status: Not Approved
Approved Countries: None
Approved Indications: None
Company: PropellaTherapeutics,Inc./Jiangsu Aosaikang Pharmaceutical Co., Ltd./FrontageLaboratories,Inc.
Company Location:
Company Founding Year: None
Additional Commercial Interests: None
Clinical Description
Countries in Clinic: China
Active Clinical Trial Count: 3
Recent & Upcoming Milestones
Highest Development Phases
Phase 2: Osteoarthritis, Knee
Trial ID |
Trial |
Phase |
Trial Status |
Disease |
Primary Completion Date |
Probability of Success |
Latest Trial Update Date |
Data Updated |
|---|---|---|---|---|---|---|---|---|
NCT06614608 |
ASKC200 | P1 |
Not yet recruiting |
Osteoarthritis, Knee |
2025-04-01 |
2024-09-27 |
||
CTR20243377 |
CTR20243377 | P1 |
Active, not recruiting |
Osteoarthritis, Knee |
None |
2025-11-09 |
Start Date|Treatments|Trial Status |
|
CTR20253713 |
CTR20253713 | P2 |
Active, not recruiting |
Osteoarthritis, Knee |
None |
2026-04-28 |
Treatments|Trial Status |
Recent News Events
Date |
Type |
Title |
|---|
